Âé¶ą´«Ă˝É«ÇéƬ

Journal News

Prion origins are key in study of chronic wasting disease

Aswathy Rai
Oct. 6, 2022

Chronic wasting disease, or CWD, is a contagious and fatal prion disorder that affects cervid species such as deer, elk, caribou, reindeer and moose. Cervids of all ages, captive and wild, can be affected. 

The Centers for Disease Control and Prevention reports that CWD is prominent in the continental U.S., Canada, Norway, Finland, Sweden and South Korea. Increased prevalence and spread of CWD endangers cervid populations in these regions. No vaccine or treatment exists. 

Prions are misfolded proteins with the ability to transmit their misfolded shape onto normal variants of the same protein. They characterize several fatal and transmissible neurodegenerative diseases in humans and many other animals.
Prions are misfolded proteins with the ability to transmit their misfolded shape onto normal variants of the same protein. They characterize several fatal and transmissible neurodegenerative diseases in humans and many other animals.

Like any prion disease, CWD is characterized by the misfolding of a normal protease-sensitive host protein, or PrPC, to a protease-resistant isoform, or PrPSc. The misfolded pathogenic PrPSc has distinct biochemical profiles that correlate with specific disease characteristics. CWD spreads when PrPSc is shed into the environment through urine, feces, bodily fluids or carcasses or by direct animal-to-animal contact. 

leads a team at Colorado State University that studies prion diseases.

“Chronic wasting disease can have serious consequences,” he said. “In Colorado and Wyoming, where the disease was first discovered, prevalence rates in specific herds are estimated to be between 30% and 50%. This rate in population decline can lead to local extinction of cervid species.”

Although CWD is a neurodegenerative disease, in cervids, PrPSc proteins are primarily of lymphogenic origin. Once PrPSc enters the body via oral or intranasal ingestion, it is replicated in the retropharyngeal lymph nodes, or LN. The PrPSc eventually accumulates in the obex, a region in the medulla of the central nervous system, or CNS, resulting in wasting and spongiform encephalopathy.

Typical of prion diseases, CWD is neurological, and the CNS has the highest prion concentration, so research has focused on brain-derived prions. However, the infectious prions shed in CWD primarily originate in the lymphoreticular system.

In a in the Journal of Biological Chemistry, Zabel’s team reports differences in the biochemical profiles of prion strains of lymphogenic and neurogenic origins in free-ranging white-tailed deer. 

Zabel and his team report that paired obex and LN-derived prions from the same animal showed no significant differences in conformational stability, nor was interanimal variation within the same tissue substantial. 

Glycoform ratio analysis showed differences in glycosylation patterns in prions derived from the obex and LN in the same animal. To the team’s surprise, LN-derived glycosylation patterns showed only marginal differences among animals, but brain-derived prions showed significant differences. 

Using an ELISA-based structural profiling assay, the authors also saw greater conformational diversity in LN-derived prions than brain-derived prions. 

“Prions that exist in infected animals are typically not a singular species but a sort of quasi-species or a cloud of different subspecies,” Zabel said. “We would argue that predominant species are selectedinside the animal from a large pool of diverse prions.” 

Based on their observations, the authors propose that predominant isoforms of neurogenic PrPSc are selected by the brain from a larger pool of LN-derived PrPSc. The neurogenic prion strains selected can vary considerably from animal to animal.

Extraneural prion strains shed into the environment may have a lower species barrier than neurogenic prions. The ability to transmit infectious prions between species increases the zoonotic potential, or the ability to infect humans, of CWD. The study underscores the importance of including strain properties alongside prion positivity as a criterion for diagnostic tests used by wildlife management agencies. 

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Aswathy Rai

Aswathy N. Rai is an assistant teaching professor and undergraduate coordinator at Mississippi State University's department of biochemistry, molecular biology, entomology and plant pathology. She is an ASBMB Today volunteer contributor.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

How scientists identified a new neuromuscular disease
Feature

How scientists identified a new neuromuscular disease

Aug. 14, 2025

NIH researchers discover Morimoto–Ryu–Malicdan syndrome, after finding shared symptoms and RFC4 gene variants in nine patients, offering hope for faster diagnosis and future treatments.

Unraveling cancer’s spaghetti proteins
Profile

Unraveling cancer’s spaghetti proteins

Aug. 13, 2025

MOSAIC scholar Katie Dunleavy investigates how Aurora kinase A shields oncogene c-MYC from degradation, using cutting-edge techniques to uncover new strategies targeting “undruggable” molecules.

How HCMV hijacks host cells — and beyond
Profile

How HCMV hijacks host cells — and beyond

Aug. 12, 2025

Ileana Cristea, an ASBMB Breakthroughs webinar speaker, presented her research on how viruses reprogram cell structure and metabolism to enhance infection and how these mechanisms might link viral infections to cancer and other diseases.

Understanding the lipid link to gene expression in the nucleus
Profile

Understanding the lipid link to gene expression in the nucleus

Aug. 11, 2025

Ray Blind, an ASBMB Breakthroughs speaker, presented his research on how lipids and sugars in the cell nucleus are involved in signaling and gene expression and how these pathways could be targeted to identify therapeutics for diseases like cancer.

Receptor antagonist reduces age-related bone loss in mice
Journal News

Receptor antagonist reduces age-related bone loss in mice

Aug. 6, 2025

Receptor antagonist reduces bone loss and promotes osteoblast activity in aging mice, highlighting its potential to treat osteoporosis. Read more about this recent JBC paper.

Engineered fusion protein targets kiwifruit pathogen
Journal News

Engineered fusion protein targets kiwifruit pathogen

Aug. 6, 2025

Synthetic protein selectively kills kiwifruit pathogen, offering a promising biocontrol strategy for agriculture. Read more about this recent JBC paper.